News

An upcoming study hopes to expand the use of tumor treating fields (TTFields) from only glioblastoma (grade IV tumors) into also treating grade III anaplastic astrocytomas as well.

Patients in a small study who were placed on a certain diet plan for three months saw a decrease in fatigue from breast cancer treatments.

A recent study found that a significant number of patients with advanced lung cancer were not receiving potentially beneficial treatment.

Tips to stay healthy this winter from Genny's Hope Foundation

A recent study sought to evaluate clinician expectations of benefits and harms of treatments, imaging, and screening.

Denise Yardley discusses the tnAcity study for patients with metastatic triple-negative breast cancer (TNBC), and nab-paclitaxel.

The antidiabetic agent, pioglitazone, may possibly increase the risk of bladder cancer, according to the FDA.

A recent study evaluated the relationship between polycystic ovarian syndrome (PCOS), long or irregular periods, and ovarian cancer risk.

For patients with rectal cancer, the "watch-and-wait" approach of avoiding surgery after induction therapy is emerging as a treatment option.

The FDA has granted accelerated approval of ibrutinib for treatment of marginal zone lymphona (MZL).

TESARO, manufacturer of the PARP inhibitor niraparib has opened an expaned access program (EAP) for women with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer after complete or partial response to platinum-based chemotherapy.

As the Affordable Care Act (ACA, or Obamacare) seems to hang in the balance, medical organizations, advocacy groups and patients speak out on what they hope to see in the future of healthcare.

Patients with esophogeal cancers who received induction chemotherapy, followed by PET imaging to determine whether alternative chemotherapy was needed had improved pathologic complete response rates

According to new analysis, patients with metastatic colorectal cancer (mCRC) who engaged in daily exercise demonstrated improved outcomes.

A recent study looked at the role that patients' stress and anxiety plays in deciding on treatment for patients with prostate cancer.

ASCO recently released 7 principles for patient-centered healthcare reform.

On January 19, we'll be co-hosting a tweet chat with CURE magazine and Jen Sotham about the phrases and language used by the cancer community. Join us at 9 p.m. EST with the hashtag #CureConnect

A recent study aimed to determine the when and why chemotherapy-induced cognitive impairment, or chemobrain, occurs, who is most likely to develop it, and whether certain factors (such as age, race, menopausal status, etc) play any role.

In some cases, patients with cancer who are rejected from clinical trials because they are "too sick," are the patients who would benefit the most from the trial.

The FDA cautions against use of the agent PNC-27, which claims to treat and cure all cancers, as the bacteria Variovorax paradoxus has been found in it.

Carly O’Brien, caregiver program coordinator for CancerCare, dicusses some of the best tips and resources to deal with some of the challenges of head and neck cancer.

Expert Michael Morris, MD, discusses the current and future role of radium-223 dichloride in treatment for patients with metastatic castration-resistant prostate cancer (mCRPC).

It is important that caregivers for patients with lung cancer take care of themselves and ask for help when needed. This will ultimately make them better able to care for their loved ones.

When clinicians explain randomization, a patient's understanding often depends on the individual patient’s level of health literacy and the language the clinician uses.

For patients with HPV-related oropharyngeal squamous cell carcinoma, induction chemotherapy plus reduced-dose radiation and weekly cetuximab brought improvements for swallowing and nutritional status along with complete clinical responses.

Contrary to popular belief, it is possible to have a healthy pregnancy with a breast cancer diagnosis, as long as treatment is monitored and administered correctly.

A blood test that tracks patients’ antibody levels could predict when oropharyngeal cancer is likely to recur during its earliest.

The Insight web-based program led to improvements in chemotherapy-induced cognitive symptoms and may be an effective and cost-effective treatment.

Immunotherapy agents are drastically changing the treatment landscape – and outcomes – of patients with head and neck cancers.

Longer intervals between zoledronic acid doses for patients with bone metastases did not result in an increased risk of skeletal-related events (SREs).